[Diagnostic of prostate cancer: conventional and molecular or cell biological methods].

作者: M. Susani , L. Kenner , Z. Culig

DOI: 10.1007/S00292-009-1213-5

关键词:

摘要: At present the diagnosis of prostate cancer is carried out by transrectally obtained biopsy samples. The histological findings, value for prostate-specific antigen (PSA) in serum, and clinical stage are objective criteria all subsequent therapy decisions. In over 95% cases an acinar "usual" form diagnosed but can be very different characteristics differentiation. order to correctly assess able select best possible therapeutic measures resulting from diagnosis, information must used a maximum. demands on optimal findings have considerably expanded recent years. It obtain additional biological, molecular genetic material.

参考文章(19)
Hannes Neuwirt, Martin Puhr, Frédéric R. Santer, Martin Susani, Wolfgang Doppler, Gemma Marcias, Veronika Rauch, Maria Brugger, Alfred Hobisch, Lukas Kenner, Zoran Culig, Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases The American Journal of Pathology. ,vol. 174, pp. 1921- 1930 ,(2009) , 10.2353/AJPATH.2009.080751
YOSHIO NAYA, JOEL W. SLATON, PATRICIA TRONCOSO, KOJI OKIHARA, R. JOSEPH BABAIAN, Tumor Length and Location of Cancer on Biopsy Predict for Side Specific Extraprostatic Cancer Extension The Journal of Urology. ,vol. 171, pp. 1093- 1097 ,(2004) , 10.1097/01.JU.0000103929.91486.29
L Tam, L M McGlynn, P Traynor, R Mukherjee, J M S Bartlett, J Edwards, Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer British Journal of Cancer. ,vol. 97, pp. 378- 383 ,(2007) , 10.1038/SJ.BJC.6603871
Jeremy A Squire, TMPRSS2-ERG and PTEN loss in prostate cancer. Nature Genetics. ,vol. 41, pp. 509- 510 ,(2009) , 10.1038/NG0509-509
David I. Quinn, Susan M. Henshall, Phillip C. Brenner, Raji Kooner, David Golovsky, Gordon F. O'Neill, Jennifer J. Turner, Warick Delprado, John J. Grygiel, Robert L. Sutherland, Phillip D. Stricker, Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer. ,vol. 97, pp. 1884- 1893 ,(2003) , 10.1002/CNCR.11263
Christian Vutuc, Thomas Waldhoer, Gerhard Lunglmayr, Wolfgang Hoeltl, Gerald Haidinger, PSA testing in Austria: induced morbidity and saved mortality. European Journal of Cancer Prevention. ,vol. 18, pp. 377- 380 ,(2009) , 10.1097/CEJ.0B013E32832E092F
Lars Häggarth, Christer Busch, Mona Norberg, Michael Häggman, Bo-Johan Norlén, Lars Egevad, Prediction of the volume of large prostate cancers by multiple core biopsies. Scandinavian Journal of Urology and Nephrology. ,vol. 39, pp. 380- 386 ,(2005) , 10.1080/00365590500202436
Antonio Lopez-Beltran, Gregor Mikuz, Rafael J. Luque, Roberta Mazzucchelli, Rodolfo Montironi, Current practice of Gleason grading of prostate carcinoma Virchows Archiv. ,vol. 448, pp. 111- 118 ,(2006) , 10.1007/S00428-005-0102-4
Jonathan I Epstein, William C Allsbrook Jr, Mahul B Amin, Lars L Egevad, ISUP Grading Committee, None, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma The American Journal of Surgical Pathology. ,vol. 29, pp. 1228- 1242 ,(2005) , 10.1097/01.PAS.0000173646.99337.B1